Fresenius Medical Care AG & Co. KGaA

$ 38.37 0.33 (0.87%)
Volume: 86,950 Avg Vol (1m): 241,461
Market Cap $: 23.43 Bil Enterprise Value $: 38.55 Bil
P/E (TTM): 10.59 P/B: 1.68
Earnings Power Value 6.58
Net Current Asset Value -23.55
Tangible Book -5.42
Projected FCF 39.22
Median P/S Value 45.42
Graham Number 0
Peter Lynch Value 43.39
DCF (FCF Based) 34.42
DCF (Earnings Based) 52.74
1Y (-%)

FMS News and Headlines - Fresenius Medical Care AG &. KGaA

GuruFocus Articles Total 28
  • 1
  • 2

Fresenius appears better prepared than DaVita for market transition from outpatient to home dialysis caused by the Trump kidney initiative

Over 100,000 people are currently waiting for a kidney transplant. In a small step towards ameliorating this situation, President Donald Trump earlier this week issued an executive order for Federal government to begin reimbursing kidney donors for lost wages and child care, the economic equivalent of paying for kidneys, at least by the government, if not private people.

To the extent that this move lowers the overall demand for kidney dialysis, both market leaders DaVita (DVA) and Fresenius (FMS) will suffer somewhat. Longer term though, Fresenius looks to be more prepared for this move by Trump than DaVita. Here’s

267 Views    Matt Winkler    2019-07-12 15:09

PR Newswire

WALTHAMMass., July 10, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, is pleased the U.S. administration's plans for changing the way care is provided to people with kidney disease supports its existing strategy. The company has long worked on various initiatives to promote home dialysis, improve access to transplants, and develop new, value-based care models for chronic kidney disease patients.

0 Views    PRNewswire    2019-07-11 00:07

Largest Distribution Center on East Coast Will Allow Expansion of Manufacturing Plant and Support Increasing Number of Patients with Kidney Failure Choosing Home Dialysis

PR Newswire

KNOXVILLE, Tenn., May 29, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, today celebrated the groundbreaking for a new distribution center in Knoxville, Tenn., which will help support the company's efforts to increase the number of patients with kidney

0 Views    PRNewswire    2019-05-29 20:01

NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA (“Fresenius” or the “Company”) (: FMS).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The investigation concerns whether Fresenius and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On February 25,

0 Views    Marketwired    2019-04-18 20:00

NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA (“Fresenius” or the “Company”) (: FMS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The investigation concerns whether Fresenius and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On February 25,

0 Views    Marketwired    2019-04-12 20:00

BAD HOMBURG, GERMANY / ACCESSWIRE / February 21, 2019 / Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it has filed the annual report 2018 under form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website (freseniusmedicalcare.com) in the "Investors" section as well as at the SEC's website, (www.sec.gov).

A hard copy of Fresenius Medical Care's annual report on form 20-F including the complete audited financial statements may be obtained from the company free of charge

0 Views    ACCESSWIRE    2019-04-12 04:24
Gilead, Activision Blizzard make the list

According to the GuruFocus All-in-One Screener, the following stocks are trading at a discount and have positive three- to five-year future earnings estimates.

Autoliv Inc. (ALV) is trading around $78 per share. The discounted cash flow calculator gives the stock a fair value of $101.98 per share, suggesting it has a 23% margin of safety at current prices.

547109879.png

The manufacturer of passive and active safety systems has a GuruFocus profitability and growth rating of 6 out of 10. Its earnings per share have increased 0.60% over the last five years. Analysts project a

121 Views    Tiziano Frateschi    2019-03-14 15:36

PR Newswire

WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc. (NxStage), following approval by antitrust authorities in the United States.

(PRNewsfoto/Fresenius Medical Care North Am)

NxStage develops, produces and markets an innovative product portfolio of medical devices for use in home dialysis and

0 Views    PRNewswire    2019-02-26 13:06
Company well positioned to meet demands for medical devices that demonstrate value

Medical device companies need to focus on value and disease prevention or their products risk becoming commodities, according to a recent report by consulting firm KPMG. The companies that are successful will capture the lion’s share of a worldwide market that is expected to grow at a 5% annual pace, reaching $800 billion by 2030.

Several companies were cited for forward thinking for making their products “smarter” through linkups with data providers. One is Zimmer Biomet Holdings Inc. (ZBH), an Indiana-based provider of musculoskeletal health care products and solutions. The $8 billion company is employing the engagement app

75 Views    Barry Cohen    2019-01-24 19:56

Agreement brings innovative CytoSorb® therapy to Korea and Mexico and sets the stage for future growth

PR Newswire

MONMOUTH JUNCTION, N.J., Jan. 22, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced today that it has expanded its partnership with Fresenius Medical Care to Korea and Mexico.

0 Views    PRNewswire    2019-01-22 13:06
Viacom tops the list

According to the GuruFocus All-in-One Screener, the following stocks are trading at a discount and have positive three- to five-year future earnings estimates.

Viacom Inc. (VIA) is trading around $29 per share. The discounted cash flow calculator gives the stock a fair value of $52.04 per share, suggesting it has a 44% margin of safety.

1902169645.png

GuruFocus gives the media company a profitability and growth rating of 7 out of 10. Its earnings per share have fallen 4.10% over the last five years. Analysts project a three-year to five-year earnings growth rate of 5.16%. The

171 Views    Tiziano Frateschi    2018-12-27 20:13
First Horizon, Redwood on the list

According to the GuruFocus All-in-One Screener, the following companies with market caps over $5 billion look cheap since they are trading with low price-sales ratios.

International Speedway Corp. Class A (ISCA) shares are trading around $42.10 with a price-sales ratio of 2.66 and a price-earnings ratio of 6.87. The company, which operates 13 motorsports stadiums, has a market cap of $1.88 billion. The stock has risen at an annualized rate of 5.0% over the last 10 years.

650575748.png

John Rogers (Trades, Portfolio) is the company's largest shareholder among the gurus with

63 Views    Tiziano Frateschi    2018-12-26 20:24

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LiveRamp Holdings, Inc. (:RAMP), Five Point Holdings, LLC (:FPH), Corporate Capital Trust, Inc. (:CCT), Fresenius Medical Care AG & Co. KGaA (:FMS), Lsb Industries Inc. (:LXU), and Telefonica Brasil S.A. (:VIV), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are

0 Views    Marketwired    2018-11-20 13:02
British American Tobacco makes the list

According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share (BV/S) over the last decade.

BV/S is calculated as total equity minus preferred stock, divided by shares outstanding. Theoretically, it is what shareholders will receive if a company is liquidated. Total equity is a balance sheet item and equal to total assets minus total liabilities. Since the BV/S may not reflect the company’s true value, some investors check the tangible book value to confirm their investment ideas.

The BV/S of Taiwan Semiconductor Manufacturing Co. (TSM) has grown 13% over the last 10

240 Views    Tiziano Frateschi    2018-11-04 14:33

PR Newswire

RICHMOND, Va., Nov. 1, 2018 /PRNewswire/ -- Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.

Capital Square 1031

Each property in the portfolio is 100 percent leased to Fresenius Medical Care, the

0 Views    PRNewswire    2018-11-01 16:10

PR Newswire

BOSTON, June 11, 2018 /PRNewswire/ -- Fresenius Medical Care, the world's largest provider of dialysis products and services, and Humacyte, Inc., a medical research, discovery and development company, today announced a strategic, global partnership and a $150M USD equity investment. This agreement has the potential to make Humacyte's investigational human acellular vessel, HUMACYL®, available to more patients worldwide following approval of the product. HUMACYL is currently being investigated for vascular access for

0 Views    PRNewswire    2018-06-11 16:07
After major housecleaning, the firm has worked hard to cut ties to its ill-fated investment in Valeant Pharmaceuticals

Nothing is the same about New York City-based investment firm of Ruane Cunniff (Trades, Portfolio) & Goldfarb since it dove into darkness in 2014.

There were many mistakes back then, but, after a shoddy investment nearly doomed its prospects, the famed founder of the Sequoia Fund is now staring at redemption.

In almost two years, a major housecleaning has produced an investment structure that distributes ownership, as well as decision-making, more broadly. The firm also has a new website, a new accounting system and a back to basics vision that signals its old emphasis on traditional value

250 Views    Yamil Berard    2018-02-26 23:11
Reflections on mistakes made in another investment analysis

"It's a good habit to trumpet your failures and be quiet about your successes." -Charlie Munger (Trades, Portfolio)

"Experience is what you get when you didn't get what you wanted. And experience is often the most valuable thing you have to offer.” - Randy Pausch, "The Last Lecture"

In my last article, I shared the misjudgment I made with Colfax (CFX). While it was somewhat uncomfortable to trumpet a very humbling and, to some extent, humiliating experience, I do think doing so makes me vigilant. To practice my chutzpa, I

785 Views    Grahamites    2016-12-19 16:48
A key Baxter strategy is to take advantage of the rapidly expanding market for dialysis equipment and services

In the approximately nine months since José (Joe) Almeida assumed the top job at Baxter International (BAX), shareholders have watched their investment climb nearly 30%.

The 53-year-old Brazilian native came to Baxter from Coviden, now part of Medtronic (MDT), where he served as chairman, president and CEO.

But let’s not go overboard in our praise – at least not yet. Maybe the jump in share price was just a coincidence. Or perhaps investors thought fresh blood at the helm was just the jolt the maker of rental and hospital products needed. Almeida clearly hasn’t been calling

886 Views    Barry Cohen    2016-07-01 20:50

According to GuruFocus list of 52-week highs, Fresenius Medical Care AG & Co, M&T Bank Corp, Lorillard Inc, and Lennar Corp have all reached their 52-week highs.

Fresenius Medical Care AG & Co. KGaA (FMS) Reached the 52-Week High of $42.85

Fresenius Medical Care Ag & Co. has a market cap of $25.38 billion; its shares were traded at around $42.09 with a P/E ratio of 29.70 and P/S ratio of 1.60. The dividend yield of Fresenius Medical Care Ag & Co. KGaA stocks is 1.30%. The company had an annual average earnings growth of 10.30% over the

758 Views    Jimmy Xiao    2015-04-05 21:35

Headlines Total 111
  • 1
  • 2

2019-07-12 $39.32 (-0.71%)
9:28am
2019-07-11 $39.6 (3.1%)
8:20am
2019-07-10 $38.41 (2.48%)
4:32pm
2019-07-09 $37.48 (-4.97%)
11:12am
6:48am
2019-05-30 $36.91 (-0.08%)
6:48am
2019-05-06 $42.03 (-1.68%)
10:05am
2019-05-02 $42.2 (1.25%)
2:39pm
6:18am
2019-04-18 $39.37 (-1.75%)
3:00pm
2019-04-12 $41.65 (-0.12%)
3:00pm
2019-03-26 $39.75 (1.09%)
10:48am
2019-03-25 $39.32 (1.97%)
7:37am
2019-03-19 $39.74 (0.89%)
9:41am
2019-03-14 $39.29 (-0.25%)
2:27pm
9:05am
2019-03-05 $38.63 (1.47%)
3:49pm
2019-02-27 $38.8 (-0.46%)
5:31am
2019-02-20 $39.93 (4.04%)
10:02am
2019-01-16 $34.52 (0.85%)
7:14am
2019-01-09 $34.68 (3.77%)
1:51pm
6:00am
2019-01-08 $33.42 (-0.62%)
6:21am
2019-01-03 $31.1 (-4.54%)
4:43pm
2018-10-31 $39.08 (-0.15%)
8:34am
2018-10-30 $39.14 (-1.34%)
6:44pm
10:30am
2018-10-16 $49.86 (1.98%)
8:28am
2018-10-09 $51 (0.12%)
12:22pm
2018-09-24 $51.32 (0.43%)
10:46am
2018-09-12 $50.76 (1.22%)
10:35pm
1:10pm
2018-09-07 $50.09 (-0.06%)
12:25pm
2018-09-06 $50.12 (-0.08%)
8:38am
2018-08-29 $53.37 (2.4%)
12:08pm
2018-08-01 $49.49 (1.79%)
8:18pm
8:03am
2:27am
2018-07-31 $48.62 (-2.47%)
3:59pm
10:47am
2018-07-25 $49.57 (-0.26%)
3:32pm
2018-07-10 $49 (-0.33%)
9:45am
2018-06-28 $49.82 (-0.3%)
10:22am
8:30am
2018-06-21 $50.18 (-0.73%)
2:51pm
2018-05-31 $49.92 (-1.87%)
7:08am
2018-05-18 $51.51 (-0.69%)
2:36pm
2018-05-14 $51.04 (0.65%)
10:04am
10:00am
2018-05-09 $50.26 (0.24%)
8:34am
2018-05-03 $50.04 (-2.7%)
11:27am
2018-05-02 $51.43 (1.68%)
3:34pm
8:53am
2018-04-30 $50.57 (-0.35%)
1:19pm
9:08am
7:47am
2018-04-27 $50.75 (0.81%)
4:07pm
8:42am
2018-04-23 $49.17 (-5.5%)
4:33pm
2018-04-20 $52.03 (-0.5%)
7:17am
2018-04-18 $52.78 (0.8%)
7:09am
2018-04-10 $51.24 (0.75%)
8:01am
2018-03-23 $49.78 (-0.92%)
11:58am
2018-03-22 $50.24 (-0.83%)
8:15am
2018-03-21 $50.66 (0.48%)
8:23am
2018-03-20 $50.42 (-0.22%)
8:56am
2018-03-08 $52.42 (0.34%)
3:43pm
3:12pm
2:27pm
2018-02-27 $52.92 (-3.32%)
1:55pm
11:46am
2018-02-26 $54.74 (0.31%)
10:37am
2018-02-23 $54.57 (1.28%)
9:06am
2018-02-13 $52.96 (0.51%)
6:17am
5:53am
2018-02-12 $52.69 (1.23%)
2:20pm
2018-02-09 $52.05 (1.01%)
9:15am
2018-01-20
2:38am
2018-01-04 $53.6 (1.82%)
12:11pm
2017-12-13 $52.2 (0.5%)
8:29am
2017-12-06 $51 (0.55%)
7:11am
2017-11-22 $48.92 (-0.43%)
8:10am
2017-11-21 $49.13 (1.11%)
12:45pm
2017-11-13 $48.63 (0.43%)
7:02am
2017-11-06 $48.51 (0.39%)
10:48am
2:43am
2017-10-27 $48.42 (0.23%)
11:12pm
2017-10-25 $48.59 (-0.72%)
4:30pm
2017-10-17 $48.1 (0.02%)
9:54pm
2017-10-16 $48.09 (0.1%)
4:56pm
2017-10-13 $48.04 (0.1%)
8:27am
2017-10-09 $48.3 (-1.31%)
4:19pm
2:35pm
JP Morgan: Hasta DaVita! - www.barrons.com
2:19pm
- seekingalpha.com
2017-08-17 $46.47 (-0.06%)
12:44pm
2017-08-07 $46.14 (-0.67%)
3:45pm
1:26pm
7:08am
2017-08-01 $47.33 (0.53%)
10:56am
2017-07-10 $47.84 (%)
9:45am
Total 111
  • 1
  • 2